FDA Inspection 1102380 — Avara Liscate Pharmaceutical Services SPA

Avara Liscate Pharmaceutical Services SPA — FEI 3004640070

The FDA completed an inspection of Avara Liscate Pharmaceutical Services SPA on September 20, 2019 in Liscate. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
September 20, 2019
Fiscal Year
2019
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Liscate (Italy)